| Date Filed | Type | Description |
| 04/05/2022 |
4
| Davis Thomas Andrew (CHIEF MEDICAL OFFICER) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.|
Txns:
| Sold 1,091 shares
@ $1.25, valued at
$1.4k
|
|
| 03/17/2022 |
4
| Davis Thomas Andrew (CHIEF MEDICAL OFFICER) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.|
Txns:
| Granted 31,250 shares
@ $0
Sold 2,717 shares
@ $1.1, valued at
$3k
Granted 93,750 options to buy
@ $1.11, valued at
$104.1k
|
|
| 03/16/2022 |
5
| Davis Thomas Andrew (CHIEF MEDICAL OFFICER) has filed a Form 5 on GENOCEA BIOSCIENCES, INC. |
| 03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2020 |
4
| Davis Thomas Andrew (CHIEF MEDICAL OFFICER) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.|
Txns:
| Granted 6,623 shares
@ $0
Granted 24,938 options to buy
@ $2.72, valued at
$67.8k
|
|
| 04/06/2020 |
4
| Davis Thomas Andrew (CHIEF MEDICAL OFFICER) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.|
Txns:
| Granted 12,299 shares
@ $0
Granted 46,313 options to buy
@ $1.66, valued at
$76.9k
|
|
| 02/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/01/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/09/2016 |
4
| Davis Thomas Andrew (Executive VP & CMO) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 157,000 options to buy
@ $4.72, valued at
$741k
|
|
| 06/11/2015 |
4
| Davis Thomas Andrew (Executive VP & CMO) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 116,500 options to buy
@ $25.41, valued at
$3M
|
|
| 06/05/2014 |
4
| Davis Thomas Andrew (Sr. VP & CMO) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 116,500 options to buy
@ $13.45, valued at
$1.6M
|
|
| 07/03/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/13/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/08/2011 |
4
| Davis Thomas Andrew (Sr. VP & CMO) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 104,500 options to buy
@ $2.8, valued at
$292.6k
|
|
| 09/17/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/22/2010 |
4
| Davis Thomas Andrew (Sr. VP & CMO) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 95,000 options to buy
@ $4.5, valued at
$427.5k
|
|
| 01/08/2009 |
4
| Davis Thomas Andrew (Sr. VP & CMO) has filed a Form 4 on Celldex Therapeutics, Inc. |